Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

Roche Receives FDA Approval for First Companion Diagnostic to Assess PTEN Protein in Prostate Cancer Patients

Posted by GlobeNewswire by notified on June 12, 2026

-------- Original Version -----------

Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

-------- English Version ------------

Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

-------- Link if available ----------

No Link available